Pluri Inc.
General ticker "PLUR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $135.1M (TTM average)
Pluri Inc. follows the US Stock Market performance with the rate: 2.3%.
Estimated limits based on current volatility of 4.0%: low 3.26$, high 3.54$
Factors to consider:
- Total employees count: 118 (-4.1%) as of 2024
- Top business risk factors: Operational and conduct risks, Need for additional capital, IP disputes, Regulatory and compliance, IP protection
- Price in estimated range
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [3.18$, 9.07$]
- 2025-06-30 to 2026-06-30 estimated range: [2.16$, 6.50$]
Financial Metrics affecting the PLUR estimates:
- Positive: with PPE of -0.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -65.80 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of 0.24 <= 18.93
- Positive: Investing cash flow per share per price, % of 38.64 > -0.66
Short-term PLUR quotes
Long-term PLUR plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $0.23MM | $0.29MM | $0.33MM |
| Operating Expenses | $41.83MM | $27.53MM | $22.48MM |
| Operating Income | $-41.59MM | $-27.25MM | $-22.16MM |
| Non-Operating Income | $0.22MM | $-1.64MM | $0.81MM |
| Interest Expense | $0.89MM | $0.84MM | $0.87MM |
| R&D Expense | $24.38MM | $15.74MM | $12.45MM |
| Income(Loss) | $-41.37MM | $-28.89MM | $-21.34MM |
| Profit(Loss)* | $-41.24MM | $-28.32MM | $-20.89MM |
| Stockholders Equity | $30.04MM | $13.36MM | $0.10MM |
| Assets | $68.06MM | $50.80MM | $39.53MM |
| Operating Cash Flow | $-36.50MM | $-22.86MM | $-18.02MM |
| Capital expenditure | $0.28MM | $0.26MM | $0.32MM |
| Investing Cash Flow | $11.78MM | $9.70MM | $10.58MM |
| Financing Cash Flow | $7.50MM | $8.02MM | $8.84MM |
| Earnings Per Share** | $-10.25 | $-6.18 | $-3.99 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.